Diverse usage of human T-cell receptor gene segments in HLA-DR1 allospecific T-cell clones.
T-cell recognition of alloantigen involves both the MHC molecule and its associated peptide ligand. To understand the relationship between the specificity of alloantigen recognition and the structure of TCR molecules, we have investigated TCR gene utilization by sequencing TCR genes from well-defined allospecific T-lymphocyte clones. Alloreactive TLC consisted of a panel of clones primed to recognize DR1-related alloantigens. Our sequencing results revealed extensively diverse, but nonrandom, usage of TCR AV and BV gene segments and essentially no conservation in CDR3 or junctional sequences. Such observations are consistent with allospecific TCR that interact with MHC molecules on a generic level while recognizing specific peptides. They also reduce potential enthusiasm for anti-TCR therapy in allograft rejection.
Ota
M
M
Immunogenetics Research Section, Blood Center of Southeastern Wisconsin, Milwaukee 53201-2178, USA.
Geiger
M J
MJ
Rosen-Bronson
S
S
Hurley
C K
CK
Eckels
D D
DD
D000595:Amino Acid Sequence; D001483:Base Sequence; D002999:Clone Cells; D015798:HLA-DR1 Antigen / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D007519:Isoantigens / Q000235:genetics; D008969:Molecular Sequence Data; D005810:Multigene Family / Q000276:immunology*; D011110:Polymorphism, Genetic / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D016176:T-Lymphocyte Subsets / Q000276:immunology
D015798:HLA-DR1 Antigen; D007519:Isoantigens; D011948:Receptors, Antigen, T-Cell